PROLIRA

Prolira, a high-tech SME, has formed a consortium with 3 European academic hospitals and Key Opinion Leaders, who together are revolutionizing delirium care. This is necessary as delirium has severe consequences for patients (death, dementia, slower recovery), hospitals (higher organizational-, time- and cost-consumptions), and society (costs ≈ 173 billion)... The Horizon2020 funding is a very honourful international recognition and means significant financial support. Furthermore, Prolira is proud to work together with academic Consortium Partners (UMC Utrecht (NL), Charité Universitätsmedizin Berlin (G), and Universiteitsziekenhuis Leuven (B)) for the clinical application... Every year, at least 3 million Europeans are affected by acute brain failure (delirium), especially hospitalized elderly and patients in Intensive Care Units (ICUs). And, the size of this problem will grow with our aging society. Delirium is acute failure of the brain. Each day of delirium increases the risk of..

Also known as: Prolira B.V.

Primary location: Utrecht Netherlands